Pharming Group N.V.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Latest news
All PHGUF news ›Russia’s R-Pharm launches tirzepatide drug Tirvella
Russian pharmaceutical company R-Pharm has launched a new tirzepatide-based drug on the Russian market under the trade name Tirvella. Its registration certificate was issued in August 2026. The drug is indicated for patients with type 2…
Working capital per share of Klaria Pharma Holding AB Rights 2026-28.10.26 For Units Klaria Pharm Uts 26 – OMXSTO:KLAR_UR
Klaria Pharma Holding AB engages in the development and commercialization of pharmaceutical products for migraine and cancer-related pain. Its operation is based on a patented drug delivery platform in an alginate-based polymer film. The…
3rd round of B.Pharmacy& Pharm D begins; seats allotted
Chhatrapati Sambhajinagar: The seats were allotted for the third centralised admission process (CAP) round of B.Pharmacy degree and Pharm D courses. A total of 8,720 students submitted preferences while 6,720 have been given an opportunity…
Hanmi Pharm prices domestic obesity drug Epe at half the cost of Mounjaro
First month at 129,800 won, maintenance dose at 299,200 won Early-entry and long-term cost relief backed by Pyeongtaek plant supply chain Aggressive pricing set to reshape market dominated by foreign brands South Korea's first homegrown…
Pharming Group reports 26.4% spleen reduction in Phase 2 leniolisib trial
The 13-person study had no control group and a safety primary endpoint, with a separate CVID readout expected in November. In Maastricht, the Netherlands, Phase 2 results presented on Wednesday showed a mean 26.4 per cent reduction in…
Pharming leniolisib trial: mean spleen volume down 26.4%
A 13-person, 20-week leniolisib trial shows spleen shrinkage for Pharming (PHAR). Stock Titan - [6-K] Pharming Group N.V. Current Report (Foreign Issuer) Pharming leniolisib trial: mean spleen volume down 26.4% Topline results from…
Insecurity: Pharm. Jesse Sympathizes With Garaha Community Over Fresh Boko Haram Attack
A prominent son of Hong Local Government Area, Pharm. Jesse Chidama, has sympathized with the people of Garaha community following a coordinated terrorist attack on the area on Monday evening, October 12, 2026. In a press statement…
Pharming Reports Positive Phase II Leniolisib Data in Genetic Primary Immunodeficiencies
Kalkine Media On October 14, 2026, Pharming Group N.V. submitted a Form 6-K revealing encouraging Phase II topline results for leniolisib in genetically defined primary immunodeficiencies (PIDs) with immune dysregulation. These findings…
Pharming reports positive Phase II results for leniolisib in genetic immune disorders, showing improved immune function and safety.
Pharming Group announced positive topline data from its Phase II trial of leniolisib, a drug targeting immune dysregulation in genetic primary immunodeficiencies (PIDs) beyond APDS. The trial showed leniolisib was well-tolerated and led to…
The Glass Pharms® post-harvest process explained
The quality of medical cannabis flower prescribed to patients in the UK is not determined by the cultivation process alone. Once the crop is harvested, it moves through a carefully managed post-harvest process that includes deleafing,…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
asiae.co.kr2
-
mbiz.heraldcorp.com2
-
seekingalpha.com2
-
stocktitan.net2
-
tradingview.com2
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 22 articles, not a forecast.